We are live on ! Find out more
TRAW icon

Traws Pharma
TRAW

8 hedge funds and large institutions have $3.8M invested in Traws Pharma in 2016 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

341% more capital invested

Capital invested by funds: $861K → $3.8M (+$2.94M)

100% more funds holding

Funds holding: 4 → 8 (+4)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.43M
2
BC
Boxer Capital
California
+$1.14M
3
Renaissance Technologies
Renaissance Technologies
New York
+$163K
4
EGA
Eagle Global Advisors
Texas
+$61.3K
5
AIM
Alambic Investment Management
California
+$40.8K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$102K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$40.8K
3
WMSA
Weiss Multi-Strategy Advisers
New York
-$20.4K
4
Deutsche Bank
Deutsche Bank
Germany
-$14K
5
UBS Group
UBS Group
Switzerland
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCP
1
Tyndall Capital Partners
New York
$1.45M +$1.9M +93 New
SM
2
Sabby Management
Florida
$1.04M +$1.43M +70 New
BC
3
Boxer Capital
California
$838K +$1.14M +56 New
Renaissance Technologies
4
Renaissance Technologies
New York
$256K +$163K +8 +89%
WMSA
5
Weiss Multi-Strategy Advisers
New York
$64K -$20.4K -1 -20%
Vanguard Group
6
Vanguard Group
Pennsylvania
$60K -$40.8K -2 -33%
EGA
7
Eagle Global Advisors
Texas
$44K +$61.3K +3 New
AIM
8
Alambic Investment Management
California
$36K +$40.8K +2 New
Citigroup
9
Citigroup
New York
$3K – – –
BFA
10
BlackRock Fund Advisors
California
$1K – – –
Creative Planning
11
Creative Planning
Kansas
$1K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$1K – – –
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
– -$102K -5 Closed
AIM
14
Acrospire Investment Management
Illinois
– -$5K – –
DCM
15
DAFNA Capital Management
California
– -$1K – –
Deutsche Bank
16
Deutsche Bank
Germany
– -$14K – –
UBS Group
17
UBS Group
Switzerland
– -$7K – –

TRAW Hedge Fund Activity: Q3 2016 in Review

8 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q3 2016, worth a combined $3.8M — up 341% from $861K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TRAW positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.43M. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $102K sold.

  • 8 institutional investors held Traws Pharma (TRAW) as of Q3 2016, up from 4 in Q2 2016.
  • Funds reported $3.8M of Traws Pharma stock for Q3 2016, up 341% quarter-over-quarter.
  • 5 funds opened new Traws Pharma positions in Q3 2016 and 1 closed out, a net change of +4 holders.
  • The largest Traws Pharma buyer in Q3 2016 was Sabby Management, an estimated $1.43M added.
  • The largest Traws Pharma seller in Q3 2016 was Royal Bank of Canada, an estimated $102K sold.

Based on aggregated 13F filings for Q3 2016.